PPARγ-mediated advanced glycation end products regulation of neural stem cells

Molecular and Cellular Endocrinology

Volumn 307, Issue 1-2, 2009, Pages 176-184

  Wang, Shao hua ^a   Sun, Zi lin ^a   Guo, Yi jing ^a   Yuan, Yang ^a   Li, Ling ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Advanced glycation end products; Neural stem cells; Neurogenesis; Peroxisome proliferator activated receptor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ADVANCED GLYCATION END PRODUCTS BOVINE SERUM ALBUMIN; ADVANCED GLYCATION END PRODUCTS-BOVINE SERUM ALBUMIN; BOVINE SERUM ALBUMIN; CASPASE 3; ROSIGLITAZONE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; EMBRYO; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; METABOLISM; NERVE CELL; STEM CELL;

ANIMALS; CASPASE 3; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; GLYCOSYLATION END PRODUCTS, ADVANCED; NEURONS; PPAR GAMMA; RATS; SERUM ALBUMIN, BOVINE; STEM CELLS; THIAZOLIDINEDIONES;

EID: 67349088792     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.02.012     Document Type: Article

References (45)

1. Abrous D.N., Koehl M., and Le Moal M. Adult neurogenesis: from precursors to network and physiology. Physiol. Rev. 85 (2005) 523-569
2. Brownlee M. Glycation and diabetic complications. Diabetes 43 (1994) 836-841
3. Brownlee M., Vlassara H., Kooney T., Ulrich P., and Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232 (1986) 1629-1632
4. Bucala R., Tracey K.J., and Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Invest. 87 (1991) 432-438
5. Cameron H.A., and McKay R.D. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J. Comp. Neurol. 435 (2001) 406-417
6. Chiasson B.J., Tropepe V., Morshead C.M., and van der Kooy D. Adult mammalian forebrain ependymal and subependymal cells demonstrate proliferative potential, but only subependymal cells have neural stem cell characteristics. J. Neurosci. 19 (1999) 4462-4471
7. Conti L., Sipione S., Magrassi L., Bonfanti L., Rigamonti D., Pettirossi V., Peschanski M., Haddad B., Pelicci P., Milanesi G., Pelicci G., and Cattaneo E. Shc signaling in differentiating neural progenitor cells. Nat. Neurosci. 4 (2001) 579-586
8. Doi T., Vlassara H., Kirstein M., Yamada Y., Striker G.E., and Striker L.J. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc. Natl. Acad. Sci. 89 (1992) 2873-2877
9. Edelstein D., and Brownlee M. Mechanistic studies of advanced glycation end product inhibition by aminoguanidine. Diabetes 41 (1992) 26-29
10. Erlandsson A., Enarsson M., and Forsberg-Nilsson K. Immature neurons from CNS stem cells proliferate in response to PDGF. J. Neurosci. 21 (2001) 3483-3491
11. Fu M.X., Wells-Knecht K.J., Blackledge J.A., Lyons T.J., Thorpe S.R., and Baynes J.W. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanism, and inhibition of late stages of the Maillard reaction. Diabetes 43 (1994) 676-683
12. Gage F.H. Neurogenesis in the adult brain. J. Neurosci. 22 (2002) 612-613
13. Gritti A., Parati E.A., Cova L., Frolichsthal P., Galli R., Wanke E., Faravelli L., Morassutti D.J., Roisen F., Nickel D.D., and Vescovi A.L. Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J. Neurosci. 16 (1996) 1091-1100
14. Hallbergson A.F., Gnatenco C., and Peterson D.A. Neurogenesis and brain injury: managing a renewable resource for repair. J. Clin. Invest. 112 (2003) 1128-1133
15. Haughey N.J., Nath A., Chan S.L., Borchard A.C., Rao M.S., and Mattson M.P. Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J. Neurochem. 83 (2002) 1509-1524
16. Jacobs B.L. Adult brain neurogenesis and depression. Brain Behav. Immun. 16 (2002) 602-609
17. Kihara M., Schmelzer J.D., Poduslo J.F., Curran G.L., Nickander K.K., and Low P.A. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology and oxygen free radicals. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 6107-6111
18. Kruger G.M., and Morrison S.J. Brain repair by endogenous progenitors. Cell 110 (2002) 399-402
19. Kudo C., Wada K., Masuda T., Yonemura T., Shibuya A., Fujimoto Y., Nakajima A., Niwa H., and Kamisaki Y.J. Nonylphenol induces the death of neural stem cells due to activation of the caspase cascade and regulation of the cell cycle. J. Neurochem. 88 (2004) 1416-1423
20. Launer L.J. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res. Rev. 1 (2002) 61-77
21. Lie D.C., Song H., Colamarino S.A., Ming G.L., and Gage F.H. Neurogenesis in the adult brain: new strategies for central nervous system diseases. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 399-421
22. Luchsinger J.A., Reitz C., Honig L.S., Tang M.X., Shea S., and Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65 (2005) 545-551
23. Luchsinger J.A., Tang M.X., Stern Y., Shea S., and Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am. J. Epidemiol. 154 (2001) 635-641
24. Makita Z., Bucala R., Rayfield E.J., Friedman E.A., Kaufman A.M., Korbet S.M., Barth R.H., Winston J.A., Fuh H., Manogue K.R., and Vlassara H. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 343 (1994) 1519-1522
25. McCall A.L. The impact of diabetes on the CNS. Diabetes 41 (1992) 557-570
26. Munch G., Schinzel R., Loske C., Wong A., Durany N., Li J.J., Vlassara H., Smith M.A., Perry G., and Riederer P. Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J. Neural Transm. 105 (1998) 439-461
27. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., and Breteler M.M. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53 (1999) 1937-1942
28. Peila R., Rodriguez B.L., and Launer L.J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 51 (2002) 1256-1262
29. Pugliese G., Pricci F., and Romeo G. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products (AGEs) via a receptor-mediated mechanism. Diabetes 46 (1997) 1881-1887
30. Reh T.A. Neural stem cells: form and function. Nat. Neurosci. 5 (2002) 392-394
31. Reynolds B.A., and Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. 175 (1996) 1-13
32. Shuvaev V.V., Laffont I., Serot J.M., Fujii J., Taniguchi N., and Siest G. Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol. Aging 22 (2001) 397-402
33. Song H.J., Stevens C.F., and Gage F.H. Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons. Nat. Neurosci. 5 (2002) 438-445
34. Soules-Liparota T., Cooper M., Papazoglou D., Clarke B., and Jerums G. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 40 (1991) 1328-1335
35. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., and Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci. 11 (2008) 309-317
36. Temple S. The development of neural stem cells. Nature 414 (2001) 112-117
37. Vlassara H., and Palace M.R. Diabetes and advanced glycation endproducts. J. Intern. Med. 251 (2002) 87-101
38. Wada K., Nakajima A., Katayama K., Kudo C., Shibuya A., Kubota N., Terauchi Y., Tachibana M., Miyoshi H., Kamisaki Y., Mayumi T., Kadowaki T., and Blumberg R.S. Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. J. Biol. Chem. 281 (2006) 12673-12681
39. Watson G.S., Cholerton B.A., Reger M.A., Baker L.D., Plymate S.R., Asthana S., Fishel M.A., Kulstad J.J., Green P.S., Cook D.G., Kahn S.E., Keeling M.L., and Craft S. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am. J. Geriatr. Psychiatry 13 (2005) 950-958
40. Yamagishi S., and Imaizumi T. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr. Pharm. Des. 11 (2005) 2279-2299
41. Yamagishi S., Takeuchi M., Inagaki Y., Nakamura K., and Imaizumi T. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy. Int. J. Clin. Pharmacol. Res. 23 (2003) 129-134
42. Yu X., Li C., Li X., and Cai L. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1. Toxicol. Sci. 96 (2007) 346-356
43. van Praag H., Schinder A.F., Christie B.R., Toni N., Palmer T.D., and Gage F.H. Functional neurogenesis in the adult hippocampus. Nature 415 (2002) 1030-1034
44. Zhang W.J., Tan Y.F., Yue J.T., Vranic M., and Wojtowicz J.M. Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats. Acta Neurol. Scand. 117 (2008) 205-210
45. Zitnik G., and Martin G.M. Age-related decline in neurogenesis: old cells or old environment?. J. Neurosci. Res. 70 (2002) 258-263